Differentiation potential of a mouse bone marrow stromal cell line

Journal of Cellular Biochemistry

Volumn 90, Issue 1, 2003, Pages 158-169

  Allan, Elizabeth H ^a   Ho, Patricia W M ^a   Umezawa, Akihro ^b   Hata, Jun Ichi ^b   Makishima, Fusao ^c   Gillespie, Matthew T ^a   Martin, T John ^a  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b KEIO UNIVERSITY   (Japan)

^c CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Adipocytes; Differentiation; Osteoblasts; Plasticity; Stromal cells

Indexed keywords

ALKALINE PHOSPHATASE; OSTEOCALCIN; OSTEOPONTIN; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SIALOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; MOLECULAR CLONING; MOUSE; NONHUMAN; OSTEOBLAST; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; STROMA CELL;

ADIPOCYTES; ANIMALS; BETA CATENIN; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE; CYTOSKELETAL PROTEINS; DNA PRIMERS; HEDGEHOG PROTEINS; MICE; OSTEOBLASTS; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; STROMAL CELLS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; WNT PROTEINS; ZEBRAFISH PROTEINS;

ERINACEIDAE;

EID: 0041820109     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10614     Document Type: Article

References (54)

1. Aubin J. 1998. Bone stem cells. J Cell Biochem Suppl 30/31:73-82.
2. Bellows CG, Aubin JE, Heersche JNM. 1991. Initiation and progression of mineralization of bone nodules formed in vitro: The role of alkaline phosphatase and organic phosphate. Bone Miner 14:27-40.
3. Bennett JH, Joyner CJ, Triffit JT, Owen ME. 1991. Adipocyte cells cultured from marrow have osteogenic potential. J Cell Sci 99:131-139.
4. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME. 1992. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 102:341-351.
5. Byers BA, Pavlath GK, Murphy TJ, Karsenty G, Garcia AJ. 2002. Cell-type-dependent up-regulation of in vitro mineralization after over expression of the osteoblast-specific transcription factor Runx2/Cbfa1. J Bone Miner Res 17:1931-1945.
6. Chan GK, Deckelbaum RA, Bolivar I, Goltzman D, Karapalis AC. 2001. PTHrP inhibits adipocyte differentiation by down-regulating PPARγ activity via a MAPK-dependent pathway. Endocrinol 142:4900-4909.
7. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
8. Dang ZC, Van Bezooijen RL, Karperien M, Papapoulos SE, Löwik CWGM. 2002. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res 17:394-405.
9. Ducy P, Desbois C, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G. 1996. Increased bone formation in osteocalcin-deficient mice. Nature 382:448-452.
10. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
11. Franceschi RT, Xiao G. 2003. Regulation of the osteoblast-specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways. J Cell Biochem 88:446-454.
12. Franceschi RT, Iyer BS, Cui Y. 1994. Effects of ascorbic acid on collagen matrix formation and osteoblast differenation in murine MC3T3-E1 cells. J Bone Miner Res 9:843-845.
13. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Algrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GCM, Boles RG, Boon LM, Barrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Jüppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Lettboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard M-J, Hul WV, Vikkul M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML. 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523.
14. Gori F, Thomas T, Hicok KC, Spelberg TC, Riggs BL. 1999. Differentiation of human marrow stromal precursor cells: Bone morphogenic protein-2 increase: OSF2/ CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res 14:1522-1535.
15. Grill V, Ho P, Body JJ, Johanson SC, Lee C, Kukreja SC, Moseley JM, Martin TJ. 1991. Parathyroid hormone related protein: Elevated levels in both humoral hypercalcemia of malignancy and hypercalcaemia complicating metastatic breast cancer. J Clin Endocrinol 73:1309-1315.
16. Gutierrez S, Javed A, Tennant DK, van Rees M, Montecino M, Stein GS, Stein JB, Lian JB. 2002. CCAAT/enhancer-binding proteins (C.EBP) β and δ activate osteocalcin gene transcription and synergize with Runx2 at the cEBP element to regulate bone-specific expression. J Biol Chem 277:1316-1323.
17. Horwood NJ, Elliot J, Martin TJ, Gillespie MT. 1998. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoclastic stromal cells. Endocrinology 39:4743-4746.
18. Houssami S, Findlay DM, O'Keeffe LM, Martin TJ, Sexton PM. 1994. Heterogeneity in ligand recognition of calcitonin receptors. Endocrine J 2:127-134.
19. Howe LR, Watanabe O, Leonard J, Brown AMC. 2003. Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res 63:1906-1913.
20. Hu E, Tontonoz P, Spiegelman BM. 1995. Transdifferentiation of myoblasts by the adipogenic transcription factors PPARγ and C/EBPα. Proc Natl Acad Sci USA 92:9856-9860.
21. Ingham PW. 1998. Transducing hedgehog: The story so far. EMBO J 17:3505-3511.
22. Javed A, Barnes GL, Jasanya BO, Stein JL, Gerstenfelf L, Lian JB, Stein GS. 2001. runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: Evidence for promoter context-dependent activity of Cbfa proteins. Mol Cell Biol 21:2891-2905.
23. Jiménez MJA, Balbín M, López JM, Alvarez J, Komori T, Lópes-Otín C. 1999. Collagenase is a target of Cbfa1, a transcriptional factor of the runt gene family involved in bone formation. Mol Cell Biol 19:4431-4442.
24. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH-J, Glass DA, Hartmann C, Li L, Hwang T-H, Brayton CF, Lang RA, Karsenty G, Chan L. 2002. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157:303-314.
25. Kern B, Shen J, Starbuck M, Karsenty G. 2001. Cbfa1 contributes to the osteoblast-specific expression of type 1 collagen genes. J Biol Chem 276:7101-7107.
26. Kim HJ, Rice DP, Kettunen PJ, Thesleff I. 1998. FGF-, BMP-, and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvaria bone development. Devel 125:1241-1251.
27. Komori T, Yagi H, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao Y-H, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
28. Kondo H, Ohyama T, Ohya K, Kasugai S. 1997. Temporal changes of mRNA expression of matrix proteins and parathyroid hormone and parathyroid hormone-related protein (PTH/PTHrP) receptor in bone development. J Bone Miner Res 12:2089-2097.
29. Krishnan V, Moore TL, Ma YL, Helvering LM, Frolik CA, Valasek KM, Ducy P, Geiser AG. 2003. Parathyroid hormone bone anabolic action requires cbfa1/runx2-dependent signaling. Mol Endocrinol 17:423-435.
30. Kuri-Haruch W, Green H. 1978. Adipose conversion of 3T3 cells depends on a serum factor. Proc Natl Acad Sci USA 75:6107-6109.
31. Lecka-Czernik B, Gubrij I, Moerman EJ, Kajkenova O, Lipschit DA. 1999. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARγ2. J Cell Biochem 74:357-371.
32. Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL. 2002. Divergent effects of elective peroxisome proliferator-activated receptor-γ2 ligands on adipocyte versus osteoblast differentiation. Endocinol 143:2376-2384.
33. Lee M-S, Lowe GN, Strong DD, Wergedeal JE, Glackin CA. 1999. Twist, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. J Cell Biochem 75:566-577.
34. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. 2002. The Novel Zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29.
35. Nuttal ME, Patton AJ, Olivera DL, Nadeau DP, Gowen M. 1998. Human traebecular bone cells are able to express both osteoblastic and adipocytic phenotype: Implications for osteogenic disorders. J Bone Miner Res 13:371-382.
36. Oreffo ROC, Virdi AS, Triffit JT. 1997. Modulation of osteogenesis and adipogenesis by human serum in human bone marrow cultures. Eur J Cell Biol 74:251-261.
37. Oshima A, Tanabe H, Yan T, Lowe GN, Glackin CA, Kudo A. 2002. A novel mechanism for the regulation of osteoblast differentiation: Transcription of periostin, a member of the fasciclin 1 family, is regulated by the bHLH transcription factor Twist. J Cell Biochem 86:792-804.
38. Otto F, Thornell AP, Crompton Denzel A, Gilmour KC, Rosewell IR, Stamp GWH, Beddongton RSP, Mumdlos S, Olsen BR, Selby PB, Owen MJ. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
39. Owen ME. 1985. Lineage of osteogenic cells and their relationship to the stromal system. In: Peck WA, editor. Bone and mineral research, Vol 3. Amsterdam, New York, Oxford: Elsevier. pp 1-25.
40. Park SR, Oreffo ROC, Triffit JT. 1999. Interconversion potential of cloned human marrow adipocytes in vitro. Bone 24:549-554.
41. Partridge NC, Alcorn D, Michelangeli VP, Kemp BE, Ryan GB, Martin TJ. 1981. Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells. Endocrinol 108:213-219.
42. Ross SE, Hemati N, Longo KA, Bennet CN, Lucas PC, Erickson RL, MacDougald OA. 2000. Inhibition of adipogenesis by Wnt signalling. Science 289:950-953.
43. Sato M, Morii E, Komori T, Kawahata H, Sugimoto M, Terai K, Shimizu H, Yasui T, Ogihara H, Yasui N, Ochi T, Kitamura Y, Ito Y, Nomura S. 1998. Transcriptional regulation of osteopontin gene in vivo by PEBP2-alpha CBFA1 and ETS1 in the skeletal tissues. Oncogene 17:1517-1525.
44. Selvanmurugan N, Pulumati MR, Tyson DR, Partridge NC. 2000. Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor α1. J Biol Chem 275:5037-5042.
45. Shui C, Spelberg TC, Riggs BL, Khosla S. 2003. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J Bone Miner Res 18:213-221.
46. Spinella-Jaegl S, Rawadi G, Kawai S, Gallea S, Faucheu C, Mollat P, Coutrois B, Bergaud B, Ramez V, Blanchet AM, Adelmant G, Baron R, Roman-Roman S. 2001. Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. J Cell Sci 114:2085-2094.
47. St-Jacques B, Hammerschmidt M, McMahon AP. 1999. Indian hedgehog signalling regulates proliferation of chondrocytes and is essential for bone formation. Genes Dev 13:2072-2086.
48. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ. 1995. Rapidly forming apatitc mineral in an osteoblastic cell line (UMR106-01BSP). J Biol Chem 270:9420-9428.
49. Thirunavukkarasu K, Halladay DL, Miles RR, Yang XH, Galvin RJS, Chandrasekhar S, Martin TJ, Onyia JE. 2000. The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. J Biol Chem 275:25163-25172.
50. Umezawa A, Maruyama T, Segawa K, Shadduck R, Waheed A, Hata J-I. 1992. Multipotent marrow stromal cell line is able to induce hematopoiesis in vivo. J Cell Physiol 151:197-205.
51. Wennberg C, Hessle L, Lunberg P, Mauro S, Narisawa C, Lerner UF, Millan JL. 2000. Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J Bone Miner Res 15:1879-1888.
52. Xiao G, Wang D, Douglas M, Karsenty G, Franceshi RT. 1998. Role of the α2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem 273:32988-32994.
53. Yousfi M, Lasmoles F, Kern B, Marie PJ. 2002. Twist inactivation reduces CBFA1/RUNX2 expression and DNA binding to the osteocalin promoter in osteoblasts. Biochem Biophys Res Commun 297:641-644.
54. Yuasa T, Kataoka H, Kinto N, Iwamoto M, Enomoto-Iwamoto M, Iemura S-I, Ueno N, Shibata Y, Kurosawa H, Yamaguchi A. 2002. Sonic hedgehog is involved in osteoblast differentiation by cooperating with BMP-2. J Cell Physiol 193:225-232.